Last 12 months
Inside the activity.
0 purchase rows · 66 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 9 |
| Dec 2025 | 0 | 13 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 11 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 4 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2026 Filed Mar 27, 2026 23:54 UTC |
Haro AlexDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,170 | $0.00 Strike: $8.19 | $0.00 |
DisclosureSEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · derivative · entry 5 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,729 Underlying: Common stock · 3,170 shares Expires 2028-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:54 UTC |
Haro AlexDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 125,391 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · derivative · entry 4 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 125,391 shares Expires 2027-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:54 UTC |
Haro AlexDirector
|
Exercise / conversionCommon stock | 15,972 | $13.35 | $213,226.20 |
DisclosureSEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · nonDerivative · entry 3 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,005,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 679 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:54 UTC |
Haro AlexDirector
|
Exercise / conversionCommon stock | 3,170 | $8.19 | $25,962.30 |
DisclosureSEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · nonDerivative · entry 2 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 989,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 679 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 26, 2026 Filed Mar 27, 2026 23:54 UTC |
Haro AlexDirector
|
Exercise / conversionCommon stock | 125,391 | $2.15 | $269,590.65 |
DisclosureSEC source: 0001581760-26-000047 · wk-form4_1774655682.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 986,706 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 679 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 25, 2026 Filed Mar 27, 2026 22:50 UTC |
Antonoff LaurenDirector · Chief Executive Officer
|
GrantCommon Stock | 24,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001581760-26-000040 · wk-form4_1774651801.xml · nonDerivative · entry 1 Antonoff Lauren · CIK 0001942029 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 312,497 F1 · kind: Represents performance-based restricted stock units ("PRSUs") granted to the Reporting Person on April 9, 2025. In light of the performance-based vesting condition, this grant was not reportable under Section 16 until the performance metric was satisfied. On March 25, 2026, it was determined that the performance metric had been met. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the PRSUs vested on January 1, 2026 with the remaining 75% converting to time-based RSUs and vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each vest dat F2 · balance_after: Includes 167,632 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 25, 2026 Filed Mar 27, 2026 22:55 UTC |
Hulls ChrisDirector
|
GrantCommon Stock | 54,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001581760-26-000042 · wk-form4_1774652116.xml · nonDerivative · entry 1 Hulls Chris · CIK 0001932498 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,914 F1 · kind: Represents performance-based restricted stock units ("PRSUs") granted to the Reporting Person on April 9, 2025. In light of the performance-based vesting condition, this grant was not reportable under Section 16 until the performance metric was satisfied. On March 25, 2026, it was determined that the performance metric had been met. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the PRSUs vested on January 1, 2026 with the remaining 75% converting to time-based RSUs and vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each vest date. F2 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. F3 · balance_after: Includes 162,966 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 25, 2026 Filed Mar 27, 2026 23:53 UTC |
Burke Russell JohnChief Financial Officer
|
GrantCommon stock | 24,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001581760-26-000045 · wk-form4_1774655597.xml · nonDerivative · entry 1 Burke Russell John · CIK 0001933232 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,838 F1 · kind: Represents performance-based restricted stock units ("PRSUs") granted to the Reporting Person on April 9, 2025. In light of the performance-based vesting condition, this grant was not reportable under Section 16 until the performance metric was satisfied. On March 25, 2026, it was determined that the performance metric had been met. Each PRSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the PRSUs vested on January 1, 2026 with the remaining 75% converting to time-based RSUs and vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continuous service through each vest date. F2 · balance_after: Includes 80,838 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 19, 2026 Filed Mar 23, 2026 22:19 UTC |
Hulls ChrisDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 27,000 | $0.00 Strike: $8.19 | $0.00 |
DisclosureSEC source: 0001581760-26-000038 · wk-form4_1774304360.xml · derivative · entry 6 Hulls Chris · CIK 0001932498 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 206,801 Underlying: Common stock · 27,000 shares Expires 2028-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F6 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| March 19, 2026 Filed Mar 23, 2026 22:19 UTC |
Hulls ChrisDirector
|
SaleCommon Stock | 15,133 | $39.43 | $596,694.19 |
DisclosureSEC source: 0001581760-26-000038 · wk-form4_1774304360.xml · nonDerivative · entry 2 Hulls Chris · CIK 0001932498 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 334,319 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F4 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $39.23 to $39.71, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. F2 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. F3 · balance_after: Includes 108,371 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 19, 2026 Filed Mar 23, 2026 22:19 UTC |
Hulls ChrisDirector
|
Exercise / conversionCommon Stock | 27,000 | $8.19 | $221,130.00 |
DisclosureSEC source: 0001581760-26-000038 · wk-form4_1774304360.xml · nonDerivative · entry 1 Hulls Chris · CIK 0001932498 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 349,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 16, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F2 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. F3 · balance_after: Includes 108,371 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 22:55 UTC |
Synge JamesDirector
|
GiftCommon stock | 8,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001581760-26-000036 · wk-form4_1773960942.xml · nonDerivative · entry 1 Synge James · CIK 0001932661 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,421 F1 · kind: This transaction reflects a bona fide gift of the Issuer's stock for charitable purposes. F2 · shares: Represents shares of the Issuer's common stock underlying 25,000 Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. F3 · balance_after: Includes common stock and the number of shares of common stock underlying CDIs. F4 · balance_after: Includes 703 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:43 UTC |
Wiadrowski DavidDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,460 | $0.00 Strike: $8.19 | $0.00 |
DisclosureSEC source: 0001581760-26-000033 · wk-form4_1773780182.xml · derivative · entry 5 Wiadrowski David · CIK 0001932666 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,051 Underlying: Common stock · 7,460 shares Expires 2028-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person exercised the stock options on a cashless basis. F5 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:43 UTC |
Wiadrowski DavidDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 13,850 | $0.00 Strike: $13.35 | $0.00 |
DisclosureSEC source: 0001581760-26-000033 · wk-form4_1773780182.xml · derivative · entry 4 Wiadrowski David · CIK 0001932666 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 13,850 shares Expires 2027-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person exercised the stock options on a cashless basis. F5 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:43 UTC |
Wiadrowski DavidDirector
|
SaleCommon Stock | 5,957 | $41.34 | $246,262.38 |
DisclosureSEC source: 0001581760-26-000033 · wk-form4_1773780182.xml · nonDerivative · entry 3 Wiadrowski David · CIK 0001932666 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,679 F3 · kind: Shares of the Issuer's common stock were sold in the open market solely to cover the option exercise cost. F4 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $41.27 to $41.455, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. F2 · balance_after: Includes 738 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:43 UTC |
Wiadrowski DavidDirector
|
Exercise / conversionCommon Stock | 7,460 | $8.19 | $61,097.40 |
DisclosureSEC source: 0001581760-26-000033 · wk-form4_1773780182.xml · nonDerivative · entry 2 Wiadrowski David · CIK 0001932666 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,636 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person exercised the stock options on a cashless basis. F2 · balance_after: Includes 738 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:43 UTC |
Wiadrowski DavidDirector
|
Exercise / conversionCommon Stock | 13,850 | $13.35 | $184,897.50 |
DisclosureSEC source: 0001581760-26-000033 · wk-form4_1773780182.xml · nonDerivative · entry 1 Wiadrowski David · CIK 0001932666 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,176 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person exercised the stock options on a cashless basis. F2 · balance_after: Includes 738 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:34 UTC |
Prober Charles J.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,930 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0001581760-26-000031 · wk-form4_1773779682.xml · derivative · entry 3 Prober Charles J. · CIK 0001696247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,440 Underlying: Common stock · 7,930 shares Expires 2028-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:34 UTC |
Prober Charles J.Director
|
SaleCommon stock | 7,930 | $41.40 | $328,302.00 |
DisclosureSEC source: 0001581760-26-000031 · wk-form4_1773779682.xml · nonDerivative · entry 2 Prober Charles J. · CIK 0001696247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,456 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F2 · balance_after: Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 20:34 UTC |
Prober Charles J.Director
|
Exercise / conversionCommon stock | 7,930 | $11.18 | $88,657.40 |
DisclosureSEC source: 0001581760-26-000031 · wk-form4_1773779682.xml · nonDerivative · entry 1 Prober Charles J. · CIK 0001696247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F2 · balance_after: Includes 679 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:27 UTC |
COGHLAN JOHN PHILIPDirector
|
SaleCommon stock | 2,758 | $46.56 | $128,412.48 |
DisclosureSEC source: 0001581760-26-000029 · wk-form4_1773260842.xml · nonDerivative · entry 2 COGHLAN JOHN PHILIP · CIK 0001185999 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Held by the John Coghlan Living Trust Disclosed balance after: 5,065 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $45.95 to $46.85, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 09, 2026 Filed Mar 11, 2026 20:27 UTC |
COGHLAN JOHN PHILIPDirector
|
SaleCommon stock | 1,242 | $45.29 | $56,250.18 |
DisclosureSEC source: 0001581760-26-000029 · wk-form4_1773260842.xml · nonDerivative · entry 1 COGHLAN JOHN PHILIP · CIK 0001185999 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Held by the John Coghlan Living Trust Disclosed balance after: 7,823 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. F2 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.75 to $45.70, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:34 UTC |
Antonoff LaurenDirector · Chief Executive Officer
|
SaleCommon Stock | 17,153 | $44.86 | $769,483.58 |
DisclosureSEC source: 0001581760-26-000023 · wk-form4_1773178494.xml · nonDerivative · entry 1 Antonoff Lauren · CIK 0001942029 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 288,232 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of previously reported restricted stock units ("RSUs"). The sale was to satisfy tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · balance_after: Includes 143,367 RSUs previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:38 UTC |
Hulls ChrisDirector
|
Tax withholdingCommon Stock | 5,248 | $44.91 | $235,687.68 |
DisclosureSEC source: 0001581760-26-000025 · wk-form4_1773178712.xml · nonDerivative · entry 1 Hulls Chris · CIK 0001932498 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 322,452 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes common stock and the number of shares of common stock underlying Chess Depositary Interests ("CDIs") as converted on a 1:3 common stock to CDI ratio. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. F3 · balance_after: Includes 108,371 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 21:40 UTC |
Burke Russell JohnChief Financial Officer
|
Tax withholdingCommon stock | 5,800 | $44.91 | $260,478.00 |
DisclosureSEC source: 0001581760-26-000027 · wk-form4_1773178803.xml · nonDerivative · entry 1 Burke Russell John · CIK 0001933232 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,857 F1 · kind: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. F2 · balance_after: Includes 56,573 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 21:54 UTC |
COGHLAN JOHN PHILIPDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 31,938 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001581760-26-000021 · wk-form4_1773093260.xml · derivative · entry 4 COGHLAN JOHN PHILIP · CIK 0001185999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 31,938 shares Expires 2026-06-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 21:54 UTC |
COGHLAN JOHN PHILIPDirector
|
Exercise / conversionCommon stock | 31,938 | $0.18 | $5,748.84 |
DisclosureSEC source: 0001581760-26-000021 · wk-form4_1773093260.xml · nonDerivative · entry 1 COGHLAN JOHN PHILIP · CIK 0001185999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,672 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. F2 · balance_after: These numbers have been adjusted to reflect that the transfer of 1,672 directly held shares to the John Coghlan Living Trust, which was inadvertently reported in the Form 4 filed December 16, 2025, has not yet occurred. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:18 UTC |
Prober Charles J.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,930 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0001581760-26-000008 · wk-form4_1771449482.xml · derivative · entry 3 Prober Charles J. · CIK 0001696247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,370 Underlying: Common stock · 7,930 shares Expires 2028-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:18 UTC |
Prober Charles J.Director
|
SaleCommon stock | 7,930 | $49.02 | $388,728.60 |
DisclosureSEC source: 0001581760-26-000008 · wk-form4_1771449482.xml · nonDerivative · entry 2 Prober Charles J. · CIK 0001696247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,456 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F2 · balance_after: Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:18 UTC |
Prober Charles J.Director
|
Exercise / conversionCommon stock | 7,930 | $11.18 | $88,657.40 |
DisclosureSEC source: 0001581760-26-000008 · wk-form4_1771449482.xml · nonDerivative · entry 1 Prober Charles J. · CIK 0001696247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F2 · balance_after: Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| January 14, 2026 Filed Jan 17, 2026 00:07 UTC |
Burke Russell JohnChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 12,427 | $0.00 Strike: $3.58 | $0.00 |
DisclosureSEC source: 0001581760-26-000004 · wk-form4_1768608419.xml · derivative · entry 3 Burke Russell John · CIK 0001933232 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 419,087 Underlying: Common stock · 12,427 shares Expires 2030-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This stock option is fully vested and exercisable. Read SEC document |
| January 14, 2026 Filed Jan 17, 2026 00:07 UTC |
Burke Russell JohnChief Financial Officer
|
Exercise / conversionCommon stock | 12,427 | $3.58 | $44,488.66 |
DisclosureSEC source: 0001581760-26-000004 · wk-form4_1768608419.xml · nonDerivative · entry 1 Burke Russell John · CIK 0001933232 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The Reporting Person transferred 18,524 directly held shares to the Russell John Burke Revocable Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 72,230 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 22:01 UTC |
Prober Charles J.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,930 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0001581760-26-000002 · wk-form4_1768514489.xml · derivative · entry 3 Prober Charles J. · CIK 0001696247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,300 Underlying: Common stock · 7,930 shares Expires 2028-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the remaining shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 22:01 UTC |
Prober Charles J.Director
|
SaleCommon stock | 7,930 | $61.98 | $491,501.40 |
DisclosureSEC source: 0001581760-26-000002 · wk-form4_1768514489.xml · nonDerivative · entry 2 Prober Charles J. · CIK 0001696247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,456 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F2 · balance_after: Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 22:01 UTC |
Prober Charles J.Director
|
Exercise / conversionCommon stock | 7,930 | $11.18 | $88,657.40 |
DisclosureSEC source: 0001581760-26-000002 · wk-form4_1768514489.xml · nonDerivative · entry 1 Prober Charles J. · CIK 0001696247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F2 · balance_after: Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| December 16, 2025 Filed Dec 19, 2025 01:32 UTC |
Hulls ChrisDirector
|
SaleCommon Stock | 707 | $64.49 | $45,594.43 |
DisclosureSEC source: 0000905148-25-004433 · form4.xml · nonDerivative · entry 2 Hulls Chris · CIK 0001932498 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by ICCA Labs, LLC Disclosed balance after: 0 F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. Read SEC document |
| December 16, 2025 Filed Dec 19, 2025 01:32 UTC |
Hulls ChrisDirector
|
SaleCommon Stock | 1,139 | $63.63 | $72,474.57 |
DisclosureSEC source: 0000905148-25-004433 · form4.xml · nonDerivative · entry 1 Hulls Chris · CIK 0001932498 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by ICCA Labs, LLC Disclosed balance after: 707 F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. Read SEC document |
| December 16, 2025 Filed Dec 19, 2025 01:32 UTC |
Haro AlexDirector
|
SaleCommon Stock | 722 | $64.49 | $46,561.78 |
DisclosureSEC source: 0000905148-25-004432 · form4.xml · nonDerivative · entry 2 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by ICCA Labs, LLC Disclosed balance after: 0 F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. Read SEC document |
| December 16, 2025 Filed Dec 19, 2025 01:32 UTC |
Haro AlexDirector
|
SaleCommon Stock | 1,165 | $63.63 | $74,128.95 |
DisclosureSEC source: 0000905148-25-004432 · form4.xml · nonDerivative · entry 1 Haro Alex · CIK 0001932626 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by ICCA Labs, LLC Disclosed balance after: 722 F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The Reporting Person is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. Read SEC document |
| December 16, 2025 Filed Dec 19, 2025 01:32 UTC |
Synge JamesDirector
|
SaleCommon Stock | 1,518 | $64.49 | $97,895.82 |
DisclosureSEC source: 0000905148-25-004431 · form4.xml · nonDerivative · entry 2 Synge James · CIK 0001932661 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by ICCA Labs, LLC Disclosed balance after: 0 F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $64.36 to $64.57, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The Reporting Person has shared investment control over Carthona Capital FS Pty Ltd. ("Carthona Capital"). Carthona Capital is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein represents Carthona Capital's proportionate ownership interest in ICCA Labs, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| December 16, 2025 Filed Dec 19, 2025 01:32 UTC |
Synge JamesDirector
|
SaleCommon Stock | 2,448 | $63.63 | $155,766.24 |
DisclosureSEC source: 0000905148-25-004431 · form4.xml · nonDerivative · entry 1 Synge James · CIK 0001932661 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by ICCA Labs, LLC Disclosed balance after: 1,518 F1 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $63.36 to $64.33, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. F2 · ownership.nature: The Reporting Person has shared investment control over Carthona Capital FS Pty Ltd. ("Carthona Capital"). Carthona Capital is a member of ICCA Labs, LLC, an entity that held an aggregate of 8,219 shares of the Issuer's common stock prior to the sales reported herein. The number of shares held as reported herein represents Carthona Capital's proportionate ownership interest in ICCA Labs, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 23:11 UTC |
Prober Charles J.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,930 | $0.00 Strike: $11.18 | $0.00 |
DisclosureSEC source: 0001581760-25-000245 · wk-form4_1766013110.xml · derivative · entry 3 Prober Charles J. · CIK 0001696247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,230 Underlying: Common stock · 7,930 shares Expires 2028-04-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 1/2 of the total number of shares on April 1, 2024 and thereafter vests and becomes exercisable as to 1/24th of the total number of shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 23:11 UTC |
Prober Charles J.Director
|
SaleCommon stock | 7,930 | $68.30 | $541,619.00 |
DisclosureSEC source: 0001581760-25-000245 · wk-form4_1766013110.xml · nonDerivative · entry 2 Prober Charles J. · CIK 0001696247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,456 F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F2 · balance_after: Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 23:11 UTC |
Prober Charles J.Director
|
Exercise / conversionCommon stock | 7,930 | $11.18 | $88,657.40 |
DisclosureSEC source: 0001581760-25-000245 · wk-form4_1766013110.xml · nonDerivative · entry 1 Prober Charles J. · CIK 0001696247 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,386 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 14, 2025. The Rule 10b5-1 trading plan is a written, pre-established trading plan that provides for the automatic sale of Company stock pursuant to predetermined criteria. The Reporting Person adopted the plan at a time when they were not aware of any material nonpublic information about the Company. F2 · balance_after: Includes 1,357 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:34 UTC |
Burke Russell JohnChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $3.58 | $0.00 |
DisclosureSEC source: 0001581760-25-000243 · wk-form4_1766010874.xml · derivative · entry 3 Burke Russell John · CIK 0001933232 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 431,514 Underlying: Common stock · 2,500 shares Expires 2030-05-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This stock option is fully vested and exercisable. Read SEC document |
| December 15, 2025 Filed Dec 17, 2025 22:34 UTC |
Burke Russell JohnChief Financial Officer
|
Exercise / conversionCommon stock | 2,500 | $3.58 | $8,950.00 |
DisclosureSEC source: 0001581760-25-000243 · wk-form4_1766010874.xml · nonDerivative · entry 1 Burke Russell John · CIK 0001933232 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 72,230 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 21:10 UTC |
COGHLAN JOHN PHILIPDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 920 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001581760-25-000241 · wk-form4_1765919405.xml · derivative · entry 4 COGHLAN JOHN PHILIP · CIK 0001185999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 142,306 Underlying: Common stock · 920 shares Expires 2027-10-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock option is fully vested and exercisable. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 21:10 UTC |
COGHLAN JOHN PHILIPDirector
|
Exercise / conversionCommon stock | 920 | $2.15 | $1,978.00 |
DisclosureSEC source: 0001581760-25-000241 · wk-form4_1765919405.xml · nonDerivative · entry 1 COGHLAN JOHN PHILIP · CIK 0001185999 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,592 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The Reporting Person transferred 1,672 directly held shares to the John Coghlan Living Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended. F2 · balance_after: Includes 1,672 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. Read SEC document |
| December 09, 2025 Filed Dec 10, 2025 01:47 UTC |
COGHLAN JOHN PHILIPDirector
|
GiftCommon Stock | 3,045 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-004289 · form4.xml · nonDerivative · entry 3 COGHLAN JOHN PHILIP · CIK 0001185999 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Held by the John Coghlan Living Trust Disclosed balance after: 9,065 F5 · kind: This transaction reflects a bona fide gift of the Issuer's common stock to a donor-advised fund (DAF) for charitable purposes. The Reporting Person retains no beneficial ownership or control over the donated securities following the contribution. Read SEC document |
| December 05, 2025 Filed Dec 10, 2025 01:47 UTC |
COGHLAN JOHN PHILIPDirector
|
SaleCommon Stock | 1,100 | $77.96 | $85,756.00 |
DisclosureSEC source: 0000905148-25-004289 · form4.xml · nonDerivative · entry 2 COGHLAN JOHN PHILIP · CIK 0001185999 · Director 10b5-1 filing: Plan reported Ownership: Indirect · Held by the John Coghlan Living Trust Disclosed balance after: 12,110 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company. F4 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $77.52 to $78.41, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.